Phase II study of lipiodol chemoembolization with cisplatin and thiotepa with oral thalidomide for primary liver cancer and liver metastases

Journal article

Peer reviewed

L. G Feun, A Marini, A Echenique, J. J Guerra, J. M Yrizarry, K Stadtlander, N Savaraj, L Jeffers, C Obrien and E Schiff

Journal of clinical oncology, Vol.22(14_suppl), pp.4137-4137

2004-07-15

Metrics

5 Record Views

Title: Phase II study of lipiodol chemoembolization with cisplatin and thiotepa with oral thalidomide for primary liver cancer and liver metastases
Creators: L. G Feun - University of Miami, Miami, FL
A Marini - University of Miami, Miami, FL
A Echenique - University of Miami, Miami, FL
J. J Guerra - University of Miami, Miami, FL
J. M Yrizarry - University of Miami, Miami, FL
K Stadtlander - University of Miami, Miami, FL
N Savaraj - University of Miami, Miami, FL
L Jeffers - University of Miami, Miami, FL
C Obrien - University of Miami, Miami, FL
E Schiff - University of Miami, Miami, FL
Publication Details: Journal of clinical oncology, Vol.22(14_suppl), pp.4137-4137
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031600391802976